Viridian Therapeutics, Inc. VRDN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s enterprise value?
- Viridian Therapeutics, Inc. (VRDN) reported enterprise value of $1.86B in Q1 2026.
- How has Viridian Therapeutics, Inc.'s enterprise value changed year-over-year?
- Viridian Therapeutics, Inc.'s enterprise value increased by 85.0% year-over-year, from $1.01B to $1.86B.
- What is the long-term trend for Viridian Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s enterprise value has grown at a 116.7% compound annual growth rate (CAGR), from $58.44M to $2.79B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.